![[Press release] WHO releases updated recommendations on HIV clinical management](https://afnnews.qaasid.com/wp-content/uploads/2025/10/doctor-g67f140729-640.png)
WHO press release
05 January 2026 | Geneva — The World Health Organization (WHO) has released updated recommendations on HIV clinical management providing new and revised guidance on antiretroviral therapy, management of vertical HIV…
Category: 6. Health
-
Immunotherapy and Precision Oncology Forum (IPOF 2026)
The Immunotherapy and Precision Oncology Forum (IPOF 2026) is the 5th annual hybrid conference scheduled for Saturday, April 11, 2026, in West Chester, Ohio. Presented by the Innovative Healthcare Institute and the Journal…
Continue Reading
-
ADLM publishes updated guidance to help healthcare professionals navigate drug testing for patients in the emergency department
WASHINGTON, Jan. 5, 2026 /PRNewswire/ — The Association for Diagnostics & Laboratory Medicine (ADLM) has released updated expert guidance on urine drug testing for patients in…
Continue Reading
-
Bangladesh Respiratory Illness, Encephalitis Linked to Bats
Unexplained respiratory and neurological illnesses in Bangladesh have been identified as Pteropine orthoreoviruses (PRVs)—a group of newly emergent bat-borne viruses.
RT’s Three Key Takeaways:
- New zoonotic virus…
Continue Reading
-
Remote Alzheimer's testing: At-home blood tests can accurately detect key biomarkers – Medical Xpress
- Remote Alzheimer’s testing: At-home blood tests can accurately detect key biomarkers Medical Xpress
- A minimally invasive dried blood spot biomarker test for the detection of Alzheimer’s disease pathology Nature
- A new test can detect…
Continue Reading
-
Statins Work for Primary Prevention Even in Low-risk Patients With Type 2 Diabetes
The target trial emulation study suggests rigid risk thresholds aren’t needed to steer statin use in this group.
Using statins for primary prevention is safe and beneficial in adults with type 2 diabetes irrespective of their estimated…
Continue Reading
-
FDA approves caplacizumab for pediatric acquired thrombotic thrombocytopenic purpura
The FDA has approved Cablivi (caplacizumab-yhdp; Sanofi) for injection for the treatment of pediatric patients aged 12 years and older with acquired thrombotic thrombocytopenic purpura (aTTP), to be used in combination with plasma exchange and…
Continue Reading
-
US cuts universal child vaccine recommendations, including covid and hepatitis
An overhaul of US childhood immunisation guidelines has dropped the number of vaccines the CDC recommends from 17 to 10.
The new list of recommended vaccines, issued by the Centers for Disease Control and Prevention, includes polio and measles…
Continue Reading
